Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-02-25 @ 4:48 PM
Study NCT ID:
NCT01815294
Status:
COMPLETED
Last Update Posted:
2015-12-04
First Post:
2013-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-14
First Submit QC Date:
None
Study First Post Date:
2013-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-03
Last Update Post Date:
2015-12-04
Last Update Post Date Type:
ESTIMATED